Detalles de la búsqueda
1.
Gene-expression profiling of bortezomib added to standard chemoimmunotherapy for diffuse large B-cell lymphoma (REMoDL-B): an open-label, randomised, phase 3 trial.
Lancet Oncol
; 20(5): 649-662, 2019 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-30948276
2.
Mutation screening using formalin-fixed paraffin-embedded tissues: a stratified approach according to DNA quality.
Lab Invest
; 98(8): 1084-1092, 2018 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-29769698
3.
Differential Efficacy From the Addition of Bortezomib to R-CHOP in Diffuse Large B-Cell Lymphoma According to the Molecular Subgroup in the REMoDL-B Study With a 5-Year Follow-Up.
J Clin Oncol
; 41(15): 2718-2723, 2023 05 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-36972491
4.
Distinct genetic changes reveal evolutionary history and heterogeneous molecular grade of DLBCL with MYC/BCL2 double-hit.
Leukemia
; 34(5): 1329-1341, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-31844144
5.
Molecular High-Grade B-Cell Lymphoma: Defining a Poor-Risk Group That Requires Different Approaches to Therapy.
J Clin Oncol
; 37(3): 202-212, 2019 01 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-30523719
6.
Study protocol for a randomized controlled trial comparing the efficacy of a specialist and a generic parenting programme for the treatment of preschool ADHD.
Trials
; 15: 142, 2014 Apr 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-24767423
Resultados
1 -
6
de 6
1
Próxima >
>>